Ironwood Pharma
IRWD----
Ironwood Pharma (IRWD)
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseas...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Ironwood Pharma Analyst Rating
View MoreForecast & Rating
Jul 14, 2026Price forecast
$6.3571.16%
Forecast & RatingBuy
4analysts
- Strong buy25.00%
- Buy25.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 22 at 03:05 PM
Ironwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, files initial beneficial ownership statement
- PUBT · Jul 14 at 06:30 AM
Ironwood names Jeffrey Silber chief medical officer, succeeding Michael Shetzline
- PUBT · Jul 9 at 03:33 PM
Ironwood CFO Ronald Silver sells 127,890 shares for $578,063.80
- benzinga_article · Jul 7 at 04:05 PM
12 Health Care Stocks Moving In Tuesday's After-Market Session
- PUBT · Jun 18 at 03:15 PM
Ironwood Pharmaceuticals shareholders approve 10 million-share increase to equity incentive plan
- PUBT · Jun 17 at 03:42 PM
Ironwood Pharma Director Julie McHugh disposes of 21,571 shares worth $80,449.83
